Background: Treatment for metabolic and morphologic alterations in HIV-related
lipodystrophy include medical therapy, physical exercise, and surgical interventions …

Background HIV‐associated lipodystrophy is a disorder of fat metabolism that occurs in
patients with HIV infection. It can cause metabolic derangements and negative self …

Fat redistribution, defined by both increased abdominal visceral fat and/or decreased
abdominal, extremity, and facial subcutaneous fat, is increasingly recognized among human …

Objective: To elucidate the molecular basis of the progressive enlargement of dorso-cervical
adipose tissue, the so-called 'buffalo hump', that appears in a sub-set of patients with HIV …

Background: A syndrome of lipodystrophy, associated with hypertriglyceridaemia,
hypercholesterolaemia, hyperinsulinaemia and peripheral insulin resistance has been …

To identify clinical factors associated with the incidence of HIV-1-associated lipoatrophy, HIV-
1-infected patients in the HIV Outpatient Study (HOPS) were prospectively evaluated for …

HIV associated insulin resistance, lipodistrophy and cardiometabolic syndrome have been
extensively studied and continue to be the scope of much research. There is compelling …

Objective To identify clinical factors associated with prevalence of fat atrophy (lipoatrophy)
and fat accumulation (lipoaccumulation) in HIV-1 infected patients. Design Evaluation of HIV …

HIV-associated lipodystrophy, arising as a result of long-term therapy with antiretroviral
medications, is a complex syndrome characterized by changes in regional fat mass …